Healthcare & Life Sciences
Agendia
Netherlandsagendia.com
Agendia is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
2004
Founded
1
Investors
About Agendia
Agendia is a company founded in 2004 headquartered in the Netherlands. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Agendia develops molecular diagnostic tests to predict cancer treatment outcomes and support personalized treatment plans, with its lead product MammaPrint® being FDA-cleared and globally marketed.
Explore Agendia's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.